Good pharmacovigilance practices (GVP) are a set of measures drawn up to facilitate the performance of pharmacovigilance in the European Union. GVP apply to marketing authorisation holders, the European Medicines Agency and medicines regulatory authorities in EU Member states (source: EMA).